Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peanut allergy
Biotech
Food allergy biotech DBV is running out of cash
DBV Technologies, a French biotech working on a treatment for food allergies, says it's running out of cash.
Max Bayer
Mar 8, 2024 10:30am
One dose of peanut allergy drug stops anaphylaxis for 2 weeks
Feb 13, 2023 3:30pm
FDA slaps hold on DBV peanut allergy trial in call for changes
Sep 22, 2022 9:30am
DBV peanut allergy patch hits endpoint in phase 3 infant study
Jun 8, 2022 8:40am
